Phibro Animal Health Corporation (NASDAQ:PAHC) CFO Richard G. Johnson sold 55,529 shares of the firm’s stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $36.30, for a total transaction of $2,015,702.70. Following the completion of the sale, the chief financial officer now owns 15,900 shares in the company, valued at approximately $577,170. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Phibro Animal Health Corporation (NASDAQ PAHC) traded down 0.97% during trading on Friday, hitting $35.75. 267,714 shares of the stock traded hands. The company has a 50-day moving average price of $37.99 and a 200-day moving average price of $33.77. The stock has a market cap of $1.43 billion, a PE ratio of 22.20 and a beta of 1.36. Phibro Animal Health Corporation has a 12 month low of $24.83 and a 12 month high of $40.25.

Phibro Animal Health Corporation (NASDAQ:PAHC) last announced its quarterly earnings data on Wednesday, August 30th. The company reported $0.39 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.35 by $0.04. Phibro Animal Health Corporation had a net margin of 8.45% and a return on equity of 47.88%. The company had revenue of $194.84 million during the quarter, compared to analysts’ expectations of $192.47 million. During the same quarter in the prior year, the company earned $0.32 EPS. The firm’s revenue was up 3.0% on a year-over-year basis. Equities research analysts expect that Phibro Animal Health Corporation will post $1.57 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 27th. Stockholders of record on Wednesday, September 6th will be paid a $0.10 dividend. The ex-dividend date of this dividend is Friday, September 1st. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.12%. Phibro Animal Health Corporation’s dividend payout ratio (DPR) is 24.69%.

ILLEGAL ACTIVITY WARNING: “Insider Selling: Phibro Animal Health Corporation (PAHC) CFO Sells 55,529 Shares of Stock” was originally reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another site, it was copied illegally and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://www.americanbankingnews.com/2017/09/15/insider-selling-phibro-animal-health-corporation-pahc-cfo-sells-55529-shares-of-stock.html.

Several institutional investors have recently made changes to their positions in PAHC. Mason Street Advisors LLC boosted its stake in shares of Phibro Animal Health Corporation by 7.1% in the 1st quarter. Mason Street Advisors LLC now owns 4,333 shares of the company’s stock valued at $122,000 after purchasing an additional 286 shares in the last quarter. Victory Capital Management Inc. boosted its stake in shares of Phibro Animal Health Corporation by 79.2% in the 1st quarter. Victory Capital Management Inc. now owns 4,573 shares of the company’s stock valued at $129,000 after purchasing an additional 2,021 shares in the last quarter. State of Alaska Department of Revenue boosted its stake in shares of Phibro Animal Health Corporation by 80.9% in the 2nd quarter. State of Alaska Department of Revenue now owns 3,690 shares of the company’s stock valued at $136,000 after purchasing an additional 1,650 shares in the last quarter. Municipal Employees Retirement System of Michigan boosted its stake in shares of Phibro Animal Health Corporation by 3.6% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock valued at $162,000 after purchasing an additional 150 shares in the last quarter. Finally, KBC Group NV purchased a new stake in shares of Phibro Animal Health Corporation in the 2nd quarter valued at $166,000. 48.35% of the stock is owned by institutional investors.

A number of analysts have weighed in on PAHC shares. Piper Jaffray Companies set a $42.00 target price on shares of Phibro Animal Health Corporation and gave the company a “buy” rating in a research report on Friday, August 25th. BidaskClub downgraded shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 23rd. Credit Suisse Group downgraded shares of Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and raised their price target for the company from $29.00 to $36.00 in a research note on Friday, June 2nd. Finally, Bank of America Corporation reaffirmed an “underperform” rating and set a $33.00 price target on shares of Phibro Animal Health Corporation in a research note on Wednesday, August 23rd. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the company’s stock. Phibro Animal Health Corporation currently has an average rating of “Hold” and an average price target of $34.00.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Insider Buying and Selling by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.